Literature DB >> 32382153

Protecting the population with immune individuals.

Ole F Norheim1.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32382153     DOI： 10.1038/s41591-020-0896-2

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  4 in total

1.  Seroprevalence of immunoglobulin G antibodies against SARS-CoV-2 in Cyprus.

Authors:  Christos Papaneophytou; Andria Nicolaou; Myrtani Pieri; Vicky Nicolaidou; Eleftheria Galatou; Yiannis Sarigiannis; Markella Pantelidou; Pavlos Panayi; Theklios Thoma; Antonia Stavraki; Xenia Argyrou; Tasos Kalogiannis; Kyriacos Yiannoukas; Christos C Petrou; Kyriacos Felekkis
Journal:  PLoS One       Date:  2022-06-13       Impact factor: 3.752

2.  Seroconversion and Abundance of IgG Antibodies against S1-RBD of SARS-CoV-2 and Neutralizing Activity in the Chilean Population.

Authors:  R González-Stegmaier; K Cereceda; J L Briones; C Beltran-Pávez; A Oyarzún-Arrau; S Riquelme-Barrios; C Selman; F Yarad; M Mahave; C Caglevic; R Morales; A Aguirre; F Valiente-Echeverría; R Soto-Rifo; H Marsiglia; R Gazitua; F Villarroel-Espindola
Journal:  J Immunol Res       Date:  2021-02-19       Impact factor: 4.818

3.  Modeling serological testing to inform relaxation of social distancing for COVID-19 control.

Authors:  Alicia N M Kraay; Kristin N Nelson; Joshua S Weitz; Benjamin A Lopman; Conan Y Zhao; David Demory
Journal:  Nat Commun       Date:  2021-12-03       Impact factor: 14.919

4.  Germany's fourth COVID-19 wave was mainly driven by the unvaccinated.

Authors:  Benjamin F Maier; Marc Wiedermann; Angelique Burdinski; Pascal P Klamser; Mirjam A Jenny; Cornelia Betsch; Dirk Brockmann
Journal:  Commun Med (Lond)       Date:  2022-09-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.